Chicken β-actin (CBA) or liver-specific thyroxine-binding globulin (TBG) promoters plus the CMV enhancer have been hypothesized to promote increased transcription (transactivation) of genes proximal to Rian that drive the formation of HCC. The gene discussed is ACTB; the disease is hepatocellular carcinoma.